102 citations
,
January 2020 in “Recent Patents on Inflammation & Allergy Drug Discovery” In this article review, it was reported that systemic oral antifungal treatments are essential for effectively managing tinea capitis, as topical antifungals alone cannot reach the hair follicle roots but may reduce spore transmission when used alongside oral medications.
1 citations
,
July 2024 in “Clinical Case Reports” This case report documents an 8-year-old with tinea capitis, successfully treated with Terbinafine over 8 weeks, highlighting the importance of accurate diagnosis and timely intervention to prevent complications and recurrence.
63 citations
,
September 1995 in “Annals of internal medicine” This study found that higher-dose fluconazole (400 mg/d) for two months or longer commonly causes reversible alopecia, which can be resolved by discontinuing or reducing the dosage.
35 citations
,
November 1996 in “Journal of the American Academy of Dermatology” This study reports two HIV-infected men with a rare M. canis infection unresponsive to ketoconazole and terbinafine, where itraconazole was effective but prolonged treatment led to only one cure.
11 citations
,
March 2023 in “Marine Drugs” In this study, researchers isolated five new compounds from Monascus purpureus wmd2424 and found that four exhibited mild antifungal activity against several fungi.
12 citations
,
April 2005 in “Mycoses” This study found that 1-day itraconazole therapy was more effective for acute vulvovaginal candidosis than for recurrent cases, where relapses occurred despite no yeast resistance.
55 citations
,
May 2014 in “Journal of feline medicine and surgery” This review discusses feline dermatophytosis and emphasizes the importance of early detection and appropriate treatment, but it reports no new clinical results.
41 citations
,
September 2007 in “Pediatric emergency care” This review discusses the challenges in diagnosing tinea capitis and highlights the need for laboratory confirmation and systemic treatment due to the limited effectiveness of topical antifungals; no new clinical results are presented.
April 2021 in “Research Square (Research Square)” This study found that the new cocrystal formulation KET-PABA improved the antimycotic efficiency of ketoconazole and induced an anti-inflammatory response without causing skin sensitization in mice.
12 citations
,
March 2010 in “Revista iberoamericana de micología” This case report describes a Persian cat with dermatophytic pseudomycetoma that initially responded to griseofulvin treatment and surgical excision, but the condition relapsed, ultimately leading to the cat's death.
350 citations
,
June 1989 in “The American Journal of Medicine” This study suggests that itraconazole may significantly improve therapy for aspergillosis, with 12 out of 15 evaluable patients responding to the treatment.
September 2023 in “Current opinion in microbiology” This source discusses how the skin mycobiome, dominated by Malassezia fungi, may provide a unique niche that can be disrupted by environmental changes, potentially leading to the fungal pathogen C. auris overtaking Malassezia and predisposing individuals to severe infections.
November 2022 in “Indian Journal of Dermatology” This case report describes a 52-year-old woman with erythema annulare centrifugum after using topical luliconazole and oral itraconazole, suggesting a drug-induced reaction confirmed by a positive rechallenge test.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This study highlights that dermatophytosis, a common fungal skin infection in cats, caused by Microsporum and Trichophyton species, typically resolves on its own but may be more severe in immunocompromised individuals and young animals.
12 citations
,
August 2011 This paper discusses tinea capitis in adults, emphasizing that it particularly affects postmenopausal African American or Black women, and notes challenges in treatment due to antifungal resistance.
June 2026 in “International Journal of Advanced Multidisciplinary Research and Studies” This study highlights the potential of a ketoconazole antifungal hair spray as an innovative and effective topical method for treating tinea capitis, offering benefits such as easy application, improved drug penetration, and reduced systemic exposure compared to conventional treatments.
3 citations
,
January 2020 in “Acta veterinaria indonesiana” In this case study, a Persian cat with dermatophytosis showed a reduction in skin lesions after being treated with oral itraconazole and topical ketoconazole.
This study found that dermoscopy combined with calcium fluorescent white staining effectively aided in the early diagnosis and treatment evaluation of tinea capitis by highlighting specific hair changes and fluorescent patterns associated with different dermatophyte infections in a sample of 20 patients.
January 2025 in “Transplantation” In this report, Gupta et al found that transplant recipients who discontinued fluconazole prophylaxis after the first year, despite having EIA-IgM positivity for coccidioidomycosis, did not develop the infection, suggesting that stopping prophylaxis in low-risk patients might be reasonable, with ongoing monitoring.
51 citations
,
May 2008 in “Mycoses” This study found that terbinafine HCl nail solutions with or without DDAIP HCl significantly outperformed ciclopirox nail lacquer in treating guinea pig dermatophytosis, suggesting potential effectiveness for human nail infections.
April 2017 in “The journal of investigative dermatology/Journal of investigative dermatology” In a guinea pig model of dermatophytosis, this study found that subcutaneous CD101, dosed once weekly, demonstrated significant clinical and mycological efficacy compared to the vehicle control and the oral antifungal terbinafine, suggesting potential for CD101 in treating fungal skin infections.
July 2015 in “Actas Dermo-Sifiliográficas” A young woman with a rare fungal infection showed significant improvement after treatment with antifungal medication.
97 citations
,
January 1996 in “Clinical infectious diseases/Clinical infectious diseases (Online. University of Chicago. Press)” The researchers reported that fluconazole was only modestly effective for treating sporotrichosis, particularly for osteoarticular or visceral cases, and is best considered a second-line treatment.
June 2024 in “Infection and Drug Resistance” This study reports a rare case of tinea capitis in an adult female, where Malassezia species may facilitate Microsporum canis growth, and successful treatment with oral antifungals led to rash resolution and hair regrowth.
72 citations
,
June 2013 in “Journal of feline medicine and surgery” This review discusses the infection dermatophytosis in cats and reports no new results; it emphasizes the difficulty of eradicating the disease in shelters and catteries.
June 2025 in “ARSHI Veterinary Letters” In this case study, a 5-month-old cat with dermatophytosis caused by Microsporum canis showed resolution of skin symptoms and hair regrowth after receiving topical antifungal shampoo and systemic itraconazole treatment for two weeks.
8 citations
,
March 2010 in “Chinese medical journal/Chinese Medical Journal” This study found that antifungal therapy significantly reduced pustules in patients with refractory acne, indicating a potential role for Malassezia infection in such cases.
6 citations
,
June 2017 in “Aesthetic Surgery Journal” This case report describes a 26-year-old woman who developed an unusual fungal skin infection, possibly facilitated by using a microneedling device at home, highlighting the need for safer procedures and aftercare protocols to prevent infection.
November 2024 in “PubMed” This case report describes an 18-month-old boy who developed a rare phototoxic skin reaction to terbinafine, likely triggered by sunlight exposure, which resolved after treatment with corticosteroid cream and sun avoidance.
2 citations
,
September 2018 in “JAAD case reports” This report describes a rare case of folliculotropic and syringotropic CD8 mycosis fungoides with unusual widespread mucosal involvement.